Palatability and treatment efficacy of various ibuprofen formulations in c57bl/6 mice with ulcerative dermatitis

Journal of the American Association for Laboratory Animal Science

Volumn 51, Issue 5, 2012, Pages 609-615

  Ezell, Paula C ^a,b   Papa, Luis ^a   Lawson, Gregory W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CAPSULE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FLUID INTAKE; FOOD INTAKE; GROOMING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRURITUS; PYODERMA GANGRENOSUM; SUSPENSION; TASTE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATITIS; DRINKING; FEMALE; IBUPROFEN; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RODENT DISEASES; SKIN ULCER; SOLUBILITY; TASTE; TREATMENT OUTCOME;

MUS;

EID: 84876003353     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amico JA, Vollmer RR, Cai H, Miedlar JA, Rinaman L. 2005. Enhanced initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion. Am J Physiol Regul Integr Comp Physiol 289:R1798-R1806. (Pubitemid 41643226)
2. Andrews AG, Dysko RC, Spilman SC, Kunkel RG, Brammer DW, Johnson KJ. 1994. Immune complex vasculitis with secondary ulcerative dermatitis in aged C57BL/6NNia mice. Vet Pathol 31:293-300.
3. Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG. 2002. Food intake, water intake, and drinking spout side preference in 28 mouse strains. Behav Genet 32:435-443. (Pubitemid 35364856)
4. Barnard DE, Starost MF, Teter B, Yoshizumi, Sampugna J, Morse B, Foltz C. 2006. Dietary effects on the development of ulcerative dermatitis in C57BL/6J mice. J Am Assoc Lab Anim Sci 45:115.
5. Bergstrom DH, Waranis RP, Rahman MS, Ferdinando JC. 2002. Capsules, soft. p 319. In: Swarbrick J, Boyland JC, editors. Encyclopedia of pharmaceutical technology. New York (NY): Marcel Dekker.
6. Bosgraaf CA, Johnston NA, Toth LA. 2006. Oral ibuprofen as an analgesic after abdominal surgery in mice. J Am Assoc Lab Anim Sci 45:117.
7. Dawson DV, Whitmore SP, Bresnahan JF. 1986. Genetic control of susceptibility to mite-associated ulcerative dermatitis. Lab Anim Sci 36:262-267.
8. Feldman SH, McVay L, Kassler MJ. 2006. Resolution of ulcerative dermatitis of mice by treatment with topical 0.2% cyclosporin. J Am Assoc Lab Anim Sci 45:92-93.
9. Fan W, Kouda K, Nakamura H, Takeuchi H. 2001. Effects of dietary restriction on spontaneous dermatitis in NC/Nga mice. Exp Biol Med (Maywood) 226:1045-1050.
10. Flecknell PA. 1984. The relief of pain in laboratory animals. Lab Anim 18:147-160. (Pubitemid 14136222)
11. Flecknell PA. 2004. Prescribing for laboratory animals, p 58. In: Bishop Y, editor. Veterinary formulary. London (UK): Pharmaceutical Press.
12. Forlow SB, White EJ, Thomas KL, Bagby GJ, Foley PL, Ley K. 2002. T cell requirement for development of chronic ulcerative dermatitis in E-and P-selectin-deficient mice. J Immunol 169:4797-4804. (Pubitemid 35217142)
13. Gaertner DJ, Hallman TM, Hankenson FC, Batchelder MA. 2008. Anesthesia and analgesia for laboratory rodents, p 244-245. In: Fish RE, Brown MJ, Danneman PJ, Karas AZ, editors. Anesthesia and analgesia in laboratory animals. New York (NY): Elsevier Science.
14. Haist C, Cadillac JM, Dysko RC. 2004. Assessment of bacterial contamination of drinking water provided to mice. Contemp Top Lab Anim Sci 43:8-13. (Pubitemid 40007319)
15. Haught D. 2006. [Internal document]. Effect of vitamin E levels on reproductive performance and offspring antioxidant status in mice. Purina Test Labs. Final Report SP#05-11. Document format: SP0511 Vit E on Repro Performance and offspring antioxidant status.pdf
16. Hawkins MG, Karriker MJ, Wiebe V, Taylor IT, Kass PH. 2006. Drug distribution and stability in extemporaneous preparations of meloxicam and carprofen after dilution and suspension at two storage temperatures. J Am Vet Med Assoc 229:968-974. (Pubitemid 44413900)
17. Hayes KE, Raucci JA, Gades NM, Toth LA. 2000. An evaluation of analgesic regimens for abdominal surgery in mice. Contemp Top Lab Anim Sci 39:18-23.
18. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
19. Jacoby RO, Fox JG, Davisson M. 2002. Biology and diseases of mice, p 41. In: Fox JG, Anderson LC, Loew FM, Quimby FW, editors. Laboratory animal medicine, 2nd ed. San Diego (CA): Academic Press.
20. Kastenmayer RJ, Fain MA, Perdue KA. 2006. A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background. J Am Assoc Lab Anim Sci 45:8-12. (Pubitemid 46277582)
21. Lawson GW, Sato A, Fairbanks LA, Lawson PT. 2005. Vitamin E as a treatment for ulcerative dermatitis in C57BL/6 mice and strains with a C57BL/6 background. Contemp Top Lab Anim Sci 44:18-21. (Pubitemid 41542213)
22. Liles JH, Flecknell PA. 1992. The use of nonsteroidal antiinflammatory drugs for the relief of pain in laboratory rodents and rabbits. Lab Anim 26:241-255.
23. Lipman NS. 2007. Design and management of research facilities for mice, p 309. In: Fox JG, Barthold SW, Davisson M, Newcomer CE, Quimby FW, Smith AL, editors. The mouse in biomedical research: Normative biology, husbandry, and models. San Diego (CA): Academic Press.
24. Lumpkins KC, Swing S, Emerson C, Ali F, Van Andel R. 2006. Efficacy of topical chlorhexidine for treatment of ulcerative dermatitis in C57BL/6 mice. J Am Assoc Lab Anim Sci 45:94-95.
25. McIntyre AR, Lipman NS. 2007. Amoxicillin-clavulanic acid and trimethoprim-sulfamethoxazole in rodent feed and water: Effects of compounding on antibiotic stability. J Am Assoc Lab Anim Sci 46:26-32. (Pubitemid 351171095)
26. McMahon WM, Sundberg JP. 1994. Barbering behavior abnormalities in inbred laboratory mice, p 493-497. In: Sundberg, JP, editor. Handbook of mouse mutations with skin and hair abnormalities. Animal models and biomedical tools. Boca Raton (FL): CRC Press.
27. Myers D. 1996. The effect of weaning age and diets. Bar Harbor (ME): The Jackson Laboratory.
28. Myers D. 1996. Notice to JAX mice users. Bar Harbor (ME): The Jackson Laboratory.
29. Myers D. 1997. C57BL/6J skin lesion problem eliminated. Bar Harbor (ME): The Jackson Laboratory.
30. Perkins SN, Hursting SD, Phang JM, Haines DC. 1998 Calorie restriction reduces ulcerative dermatitis and infection-related mortality in p53-deficient and wildtype mice. J Invest Dermatol 111:292-296. (Pubitemid 28354718)
31. Rainsford KD. 2009. Ibuprofen: Pharmacology, efficacy, and safety. Inflammopharmacology 17:275-342.
32. Seta S, Buttrey P. 2009. A simplified method for the treatment of mouse dermatitis. J Am Assoc Lab Anim Sci 48:608.
33. Speth RC, Smith MS, Brogan RS. 2001. Regarding the inadvisability of administering postoperative analgesics in the drinking water of rats (Rattus norvegicus). Contemp Top Lab Anim Sci 40:15-17. (Pubitemid 33674834)
34. Sundberg JP, Taylor D, Lorch G, Miller J, Silva KA, Sundberg BA, Roopenian D, Sperling L, Ong D, King LE, Everts H. 2011. 2011 primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol 48:513-524.
35. Voikar V, Polus A, Vasar E, Rauvala H. 2005. Long-term individual housing in C57BL/6J and DBA/2 mice: Assessment of behavioral consequences. Genes Brain Behav 4:240-252. (Pubitemid 40799772)
36. Williams-Fritze MJ, Scholz JA, Zeiss C, Deng Y, Wilson SR, Franklin R, Smith PC. 2011. Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background. J Am Assoc Lab Anim Sci 50:221-226.
37. World Intellectual Property Organization. [Internet]. (WO/1989/003210) Liquid ibuprofen compositions and methods of making them. [Cited December 2011]. Available: Http://www. wipo.int/pctdb/en/wo.jsp?IA=US1988003544&DISPLAY= DESC
38. World Intellectual Property Organization. [Internet]. (WO/2005/120459) Pharmaceutical composition containing a stable and clear solution of antiinflammatory drug in soft gelatin capsule and process for producing the same. [Cited December 2011]. Available: Http://www.wipo.int/pctdb/en/wo.jsp?wo=2 005120459&IA=WO2005120459&DISPLAY=DESC